Enlivex Therapeutics Ltd. Annual General and Administrative Expense in USD from 2012 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
Summary
Enlivex Therapeutics Ltd. quarterly/annual General and Administrative Expense history and growth rate from 2012 to 2023.
  • Enlivex Therapeutics Ltd. General and Administrative Expense for the quarter ending June 30, 2024 was $987K, a 38.8% decline year-over-year.
  • Enlivex Therapeutics Ltd. annual General and Administrative Expense for 2023 was $6.14M, a 13.6% decline from 2022.
  • Enlivex Therapeutics Ltd. annual General and Administrative Expense for 2022 was $7.1M, a 10.9% increase from 2021.
  • Enlivex Therapeutics Ltd. annual General and Administrative Expense for 2021 was $6.41M, a 73.2% increase from 2020.
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.14M -$965K -13.6% Jan 1, 2023 Dec 31, 2023 20-F 2024-04-30
2022 $7.1M +$697K +10.9% Jan 1, 2022 Dec 31, 2022 20-F 2024-04-30
2021 $6.41M +$2.71M +73.2% Jan 1, 2021 Dec 31, 2021 20-F 2024-04-30
2020 $3.7M +$684K +22.7% Jan 1, 2020 Dec 31, 2020 20-F 2023-04-10
2019 $3.02M +$1.73M +134% Jan 1, 2019 Dec 31, 2019 20-F 2022-04-29
2018 $1.29M +$806K +168% Jan 1, 2018 Dec 31, 2018 20-F 2021-04-30
2017 $480K -$5.42M -91.9% Jan 1, 2017 Dec 31, 2017 20-F 2020-04-30
2016 $5.9M -$1.05M -15.1% Jan 1, 2016 Dec 31, 2016 20-F/A 2020-01-23
2015 $6.95M +$4.31M +163% Jan 1, 2015 Dec 31, 2015 20-F 2018-04-23
2014 $2.64M +$2.22M +534% Jan 1, 2014 Dec 31, 2014 20-F 2017-02-24
2013 $416K +$330K +384% Jan 1, 2013 Dec 31, 2013 20-F 2016-03-29
2012 $86K Jan 1, 2012 Dec 31, 2012 20-F 2015-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.